Dr. Reddy's Laboratories Limited RDY
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -44.31% | -26.64% | 1.37% | 6.56% | -0.29% |
| Total Depreciation and Amortization | 10.65% | 15.57% | 15.98% | 21.23% | 16.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.01% | 68.27% | 957.93% | -11.71% | 193.32% |
| Change in Net Operating Assets | 43.15% | 61.69% | 47.36% | 45.45% | 1.84% |
| Cash from Operations | -24.83% | 17.82% | 68.75% | 66.83% | 19.51% |
| Capital Expenditure | 35.75% | 18.49% | -1.41% | -20.45% | -59.90% |
| Sale of Property, Plant, and Equipment | 67.54% | -43.38% | -76.26% | -76.10% | -72.71% |
| Cash Acquisitions | 94.19% | 94.56% | 96.89% | 96.89% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -173.63% | -268.10% | -219.73% | -462.09% | 170.69% |
| Cash from Investing | 29.32% | -7.25% | 10.26% | 31.14% | -6.65% |
| Total Debt Issued | 44.25% | -17.28% | -77.31% | -101.18% | -12.86% |
| Total Debt Repaid | -412.05% | 2.32% | 15.38% | -269.74% | -189.47% |
| Issuance of Common Stock | 21.35% | 105.70% | 54.46% | 64.47% | -50.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 4.10% | 4.10% | 4.10% | 4.10% | 1.09% |
| Other Financing Activities | -252.55% | -224.29% | -208.04% | -197.76% | 229.76% |
| Cash from Financing | -72.20% | -61.05% | -123.68% | -142.06% | 16.54% |
| Foreign Exchange rate Adjustments | 175.80% | 438.79% | 1,309.01% | 543.88% | 698.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -42.38% | -91.74% | -6.14% | 40.79% | 281.55% |